Wellgistics Health, Inc. 是一家以药品和医疗服务为核心的控股公司。公司总部位于佛罗里达州坦帕。该公司于2025年2月21日上市。公司专注于专科药品和社区基础模式,为患者提供药品配送上门服务。公司致力于在为药店、医疗机构、制药制造商和保险支付方提供解决方案的同时,改善患者的生活质量。其技术平台DelivMeds作为一个药房枢纽,使临床服务能够与公司的健康药房运营相连接。该平台将提供一个端到端的移动应用程序解决方案,让患者能够数字化他们的处方流程。这一解决方案有助于保障患者的自主权、提高处方药价格透明度,并提供额外的礼宾服务。其产品包括Kyzatrex、司美格鲁肽(Semaglutide)和替尔泊肽(Tirzepatide)。
WGRX stock price ended at $0.17 on 星期一, after rising 6.25%
On the latest trading day Mar 16, 2026, the stock price of WGRX rose by 6.25%, climbing from $0.17 to $0.17. Throughout the session, the stock experienced a volatility of 6.25%, with prices fluctuating between a daily low of $0.16 and a high of $0.17. Alongside this price increase, trading volume also rose by 2.4M shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 3.2M shares were traded, amounting to a market value of approximately $15.2M.